ITAT Overturns PCIT 's Revision Order: SBS Biotech Unit II Wins Section 80IC Deduction Dispute

The Income Tax Appellate Tribunal (ITAT), Chandigarh Bench “B”, recently handed down a significant judgment in ITA No. 413/Chd/2024 , reversing a Principal Commissioner of Income Tax (PCIT)'s order that overturned a valid assessment under Section 147 read with Section 144B of the Income Tax Act, 1961. The case centers on SBS Biotech Unit II's claim for a deduction under Section 80IC for the Assessment Year 2017-18.

Case Background: Disputed Section 80IC Deduction

SBS Biotech Unit II, a partnership firm manufacturing Ayurvedic products in Himachal Pradesh , claimed a 100% deduction under Section 80IC based on substantial expansion undertaken in 2012. The Assessing Officer (AO), after an inquiry, accepted this claim. The PCIT, however, initiated revision proceedings under Section 263, arguing that the AO's order was erroneous and prejudicial to the revenue's interest, primarily because the assessee was claiming a deduction beyond the legally permissible limit. The PCIT referred to the Supreme Court's decision in PCIT vs Aartham Softronics [2019] 102 Taxmann.com 343.

Arguments Presented

The assessee, SBS Biotech Unit II, contended that the PCIT improperly invoked Section 263. They argued that the AO had conducted a proper inquiry, considering all submitted documents and explanations, and that the PCIT's intervention was based on a differing opinion, not on the assessment order being inherently erroneous or prejudicial to the revenue. The assessee strongly emphasized the Supreme Court's decision in Aartham Softronics , arguing that it supported their claim to the 100% deduction. They cited numerous High Court and ITAT judgments supporting the proposition that a mere difference of opinion does not justify a Section 263 revision.

The Revenue, represented by the Department's representative, countered that the AO's order was cryptic and lacked sufficient detail to demonstrate a thorough examination of the deduction claim under Section 80IC. They maintained that even with substantial expansion, the deduction should have been capped at 25% for the assessment year in question, as per Section 80IC. The Revenue argued the PCIT rightfully invoked Section 263 given the perceived error and potential revenue loss.

ITAT's Decision and Reasoning

The ITAT carefully examined the records, including the AO's order, the assessee's submissions, and the PCIT's show-cause notice. The Tribunal noted that the PCIT's reliance on Explanation 2(a) to Section 263, which deals with orders passed without making necessary inquiries, was misplaced. The ITAT found that the AO had made adequate inquiries and reasonably concluded that SBS Biotech Unit II was entitled to the 100% deduction under Section 80IC. Crucially, the ITAT agreed with the assessee's interpretation of the Aartham Softronics judgment.

The ITAT's judgement includes the following pivotal excerpt: "In the entirety of facts and circumstances of the case, it is our considered opinion that the Assessing officer, after calling for required information/documentation and after duly considering the explanations and documentation submitted before him, reached a rightful conclusion that the assessee is eligible for claim of 100% deduction u/s 80IC of the Act for the impugned assessment year 2017-18."

Ultimately, the ITAT set aside the PCIT's order and upheld the AO's original assessment, allowing the assessee's claim for the 100% deduction.

Implications

This judgment highlights the importance of a thorough inquiry by the AO and sets a clear precedent against the arbitrary invocation of Section 263. It emphasizes that mere disagreement with the AO's interpretation of the law does not automatically justify a revision under Section 263; there must be a demonstrable error in the assessment and prejudice to the revenue. This decision provides valuable guidance to tax professionals on navigating Section 80IC deductions and the appropriate application of Section 263.